Cargando…

PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease

PURPOSE OF REVIEW: To review the current status of positron emission tomography (PET) molecular imaging research of levodopa-induced dyskinesias (LIDs) in Parkinson’s disease (PD). RECENT FINDINGS: Recent PET studies have provided robust evidence that LIDs in PD are associated with elevated and fluc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagano, Gennaro, Yousaf, Tayyabah, Politis, Marios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Neuroimaging (N Pavese, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626800/ https://www.ncbi.nlm.nih.gov/pubmed/28975571 http://dx.doi.org/10.1007/s11910-017-0794-2

Ejemplares similares

Molecular Imaging of the GABAergic System in Parkinson’s Disease and Atypical Parkinsonisms
por: Terkelsen, Miriam H., et al.
Publicado: (2022)

Brain Imaging and Impulse Control Disorders in Parkinson’s Disease
por: Roussakis, Andreas–Antonios, et al.
Publicado: (2019)

Neuroimaging in Vascular Parkinsonism
por: Ma, Karen K. Y., et al.
Publicado: (2019)

PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases
por: Ghadery, Christine, et al.
Publicado: (2019)

Gray Matter Changes in Parkinson’s and Alzheimer’s Disease and Relation to Cognition
por: Krajcovicova, Lenka, et al.
Publicado: (2019)

The Molecular Neuroimaging of Tremor
por: Pasquini, Jacopo, et al.
Publicado: (2021)

Restorative Strategies in Movement Disorders: the Contribution of Imaging
por: Lao-Kaim, Nicholas P., et al.
Publicado: (2017)

Locus Coeruleus Magnetic Resonance Imaging in Neurological Diseases
por: Galgani, Alessandro, et al.
Publicado: (2020)

Novel Imaging Biomarkers for Huntington’s Disease and Other Hereditary Choreas
por: Fazio, Patrik, et al.
Publicado: (2018)

Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
por: Wang, Yi Ting, et al.
Publicado: (2019)

Neuroimaging in Functional Movement Disorders
por: Roelofs, Jacob J., et al.
Publicado: (2019)

Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
por: Yousaf, Tayyabah, et al.
Publicado: (2019)

The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies
por: Pagano, Gennaro, et al.
Publicado: (2017)

Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naïve Parkinson’s patients
por: Polychronis, Sotirios, et al.
Publicado: (2019)

Neuroimaging of Sleep Disturbances in Movement Disorders
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
por: Wilson, Heather, et al.
Publicado: (2019)

Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
por: Wilson, Heather, et al.
Publicado: (2022)

Cesare Pavese y los intelectuales italianos : ensayos /
Publicado: (1973)

“Cueing” for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2016)

Current status of PET imaging in Huntington’s disease
por: Pagano, Gennaro, et al.
Publicado: (2016)

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism
por: Niccolini, Flavia, et al.
Publicado: (2016)

Dementia spectrum disorders: lessons learnt from decades with PET research
por: Wilson, Heather, et al.
Publicado: (2019)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
por: Bargiotas, Panagiotis, et al.
Publicado: (2013)

Future Scenarios for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Cerasa, Antonio, et al.
Publicado: (2015)

Surgical Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease
por: Krishnan, Syam, et al.
Publicado: (2017)

Cerebellar connectivity in Parkinson's disease with levodopa‐induced dyskinesia
por: Yoo, Han Soo, et al.
Publicado: (2019)

Multiplex core of the human brain using structural, functional and metabolic connectivity derived from hybrid PET-MR imaging
por: Devrome, Martijn, et al.
Publicado: (2023)

Translocator protein PET imaging in temporal lobe epilepsy: A reliable test-retest study using asymmetry index
por: Mahmud, Mohammad, et al.
Publicado: (2023)

Preserved caudate function in young-onset patients with Parkinson’s disease: a dual-tracer PET imaging study
por: Yang, Yu-jie, et al.
Publicado: (2019)

Evaluation of time-resolved whole brain flat panel detector perfusion imaging using RAPID ANGIO in patients with acute stroke: comparison with CT perfusion imaging
por: Kurmann, Christoph C, et al.
Publicado: (2023)

Hippocampal subfield imaging and fractional anisotropy show parallel changes in Alzheimer's disease tau progression using simultaneous tau‐PET/MRI at 3T
por: Carlson, Mackenzie L., et al.
Publicado: (2021)

Ictal PET in presurgical workup of refractory extratemporal epilepsy
por: Nooraine, Javeria, et al.
Publicado: (2013)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

The acute brain response to levodopa heralds dyskinesias in Parkinson disease
por: Herz, Damian M., et al.
Publicado: (2014)

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
por: Martinez-Carrasco, Alejandro, et al.
Publicado: (2023)

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
por: Martinez-Carrasco, Alejandro, et al.
Publicado: (2023)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease
por: Joseph-Mathurin, Nelly, et al.
Publicado: (2018)

Head injury is associated with tau deposition on PET in MCI and AD patients
por: Risacher, Shannon L., et al.
Publicado: (2021)

Deep learning improves utility of tau PET in the study of Alzheimer's disease
por: Zou, James, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6k4agl0hbmv22g1kv3o0o4v1gp